BMED holdings and overlap
iShares Health Innovation Active ETF (BMED) holds 55 positions in its iShares file of 2026-10-27. Its three largest are Gilead Sciences (GILD) at 5.62%, Danaher (DHR) at 5.27% and Moderna (MRNA) at 5.08%, and its ten largest make up 42.6% of the fund.
In its iShares file of 2026-10-27, BMED is 94.5% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 80.4% of BMED is in the United States, 5.6% in Switzerland, 2.5% in Belgium and 2.3% in Denmark.
What does BMED hold, as of its issuer file of 2026-10-27?
Gilead Sciences is 5.62% of BMED on its own, against a median largest position of 8.6% across the 28 Health Care funds with a page here. The position BMED carries furthest above that group is Danaher at 5.27% of the fund, a company the median fund in that group does not hold at all.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | GILD Gilead Sciences | 5.62% | |
| 2 | DHR Danaher | 5.27% | |
| 3 | MRNA Moderna | 5.08% | |
| 4 | ABBV AbbVie | 4.89% | |
| 5 | TMO Thermo Fisher Scientific | 4.39% | |
| 6 | BIIB Biogen | 3.82% | |
| 7 | IQV IQVIA | 3.67% | |
| 8 | MTD Mettler Toledo | 3.6% | |
| 9 | VRTX Vertex Pharmaceuticals | 3.24% | |
| 10 | EW Edwards Lifesciences | 3.02% | |
| 11 | MRK Merck | 2.93% | |
| 12 | ROP.CH Roche PS Par AG | 2.88% | |
| 13 | AMGN Amgen | 2.52% | |
| 14 | A Agilent Technologies | 2.46% | |
| 15 | WAT Waters | 2.34% | |
| 16 | HALO Halozyme Therapeutics | 2.28% | |
| 17 | GMAB Genmab Sponsored ADR | 2.27% | |
| 18 | DXCM Dexcom | 2.14% | |
| 19 | ILMN Illumina | 1.95% | |
| 20 | CRL Charles River Laboratories | 1.74% | |
| 21 | ARGX Argenx SE ADR | 1.72% | |
| 22 | PFE Pfizer | 1.54% | |
| 23 | GH Guardant Health | 1.46% | |
| 24 | NBIX Neurocrine Biosciences | 1.42% | |
| 25 | GALD.CH Galderma Group N AG | 1.4% | |
| 26 | TEVA Teva Pharmaceutical Industries | 1.4% | |
| 27 | ROIV Roivant Sciences | 1.33% | |
| 28 | BMY Bristol Myers Squibb | 1.32% | |
| 29 | NOVN.CH Novartis AG | 1.28% | |
| 30 | ABT Abbott Laboratories | 1.26% | |
| 31 | CYTK Cytokinetics | 1.25% | |
| 32 | JNJ Johnson & Johnson | 1.23% | |
| 33 | MRK.DE Merck | 1.22% | |
| 34 | 2269.HK Wuxi Biologics Cayman | 1.16% | |
| 35 | BMRN BioMarin Pharmaceutical | 0.98% | |
| 36 | COR Cencora | 0.96% | |
| 37 | TEM Tempus AI | 0.89% | |
| 38 | PTGX Protagonist Therapeutics | 0.86% | |
| 39 | UCB.BE Ucb SA | 0.78% | |
| 40 | AXSM Axsome Therapeutics | 0.72% | |
| 41 | BRKR Bruker | 0.7% | |
| 42 | ALKS Alkermes | 0.59% | |
| 43 | RVMD Revolution Medicines | 0.54% | |
| 44 | DNTH Dianthus Therapeutics | 0.5% | |
| 45 | PTCT PTC Therapeutics | 0.44% | |
| 46 | MBX MBX Biosciences | 0.41% | |
| 47 | COGT Cogent Biosciences | 0.41% | |
| 48 | VRDN Viridian Therapeutics | 0.34% | |
| 49 | SGMT Sagimet Biosciences | 0.14% | |
| 50 | SMMT Summit Therapeutics | 0.08% | |
| 51 | EIKN Eikon Therapeutics | 0.05% | |
| 52 | AVTX Avalo Therapeutics | 0.04% | |
| 53 | MRTX Mirati Therapeutics Inc | 0.0% | |
| 54 | DUMMY Vigil Neuroscience Inc CVR | 0.0% | |
| 55 | KRRBIO Korro Bio Inc CVR | 0.0% |
The most recent file iShares has published for BMED is dated 2026-10-27, 1 day before these prices, which is the median for the iShares ETFs covered here. Every one of the 55 positions BMED holds, with its weight, is in the fund's JSON file. See the other 123 ETFs with a page here that hold GILD, and how their weights compare with the 5.62% BMED gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-27, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/bmed.jsonhttps://tickerinside.com/api/v1/fund/bmed.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/bmed.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/bmed.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/bmed.jsonHow much money went into or out of BMED?
On the close of Friday, October 23, 2026, BMED neither created nor redeemed shares. Over its last 5 closes, a net inflow of $0.
From BMED's own holdings files. Every ETF's latest flows.
How is BMED split by sector and country?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 94.5% |
| Country | Weight | Weight bar |
|---|---|---|
| United States | 80.4% | |
| Switzerland | 5.6% | |
| Belgium | 2.5% | |
| Denmark | 2.3% | |
| Israel | 1.4% | |
| Germany | 1.2% | |
| China | 1.2% |
From its iShares file of 2026-10-27. How these are measured.
What did BMED hold in its SEC reports since 2020?
In BMED's SEC filings, its largest position went from SGEN at 3.24% on 2020-10-31 to Merck & Co. (MRK) at 5.91% on 2026-07-31, across 24 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2020-10-31 | 137 | SGEN 3.24% | 22.1% |
| 2021-10-31 | 130 | ICLR 3.22% | 25.1% |
| 2022-10-31 | 131 | VRTX 3.17% | 23.8% |
| 2023-10-31 | 124 | VRTX 3.59% | 28.1% |
| 2024-10-31 | 128 | BSX 4.89% | 31.4% |
| 2025-10-31 | 123 | ABT 3.29% | 26.3% |
| 2026-07-31 | 51 | MRK 5.91% | 41.7% |
The first report, then the last of each year, of the 24 reports BMED filed on SEC Form N-PORT from 2020-10-31 to 2026-07-31, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/bmed/{date}.json. How these are read.
What does BMED share with other ETFs?
The ETF nearest to BMED is RSPH: the two hold 35.9% of their weight in common, in the 22 companies both own, and 68.8% of BMED itself is also held there. No covered ETF holds more than that in common with BMED; it duplicates nothing here closely.
| ETF | Overlap by weight | Of BMED held there | Of that ETF in BMED | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| RSPH | 35.9% | 68.8% | 37.6% | 22 | |
| IXJ | 35.2% | 76.8% | 47.4% | 27 | |
| IYH | 34.6% | 74.9% | 52.2% | 30 | |
| XLV | 34.5% | 68.8% | 53.1% | 22 | |
| IBB | 34.3% | 43.4% | 52.2% | 25 | |
| IBBQ | 32.6% | 42.3% | 50.5% | 24 | |
| VHT | 32.5% | 84.8% | 45.5% | 40 | |
| BBH | 31.0% | 35.1% | 67.8% | 13 | |
| PBE | 26.2% | 29.8% | 42.8% | 11 | |
| PJP | 24.9% | 26.6% | 45.1% | 9 | |
| FBT | 24.1% | 29.5% | 43.1% | 13 | |
| FMED | 23.3% | 32.5% | 33.0% | 17 |
VHT's holdings are from its SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-29. BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. FBT's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. FMED's holdings are from its SEC Form N-PORT for the period ended 2026-08-31, filed 2026-10-26. The other ETFs' holdings are from their issuers' latest files. Check BMED against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to BMED?
SOXX shares 0% of weight with BMED and its weekly returns correlate with it at 0.31 over three years. The table lists the covered ETFs with the least in common with BMED, least shared weight first and, among equals, lowest correlation.
| ETF | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| SOXX | iShares Semiconductor ETF | 0.0% | 0.31 | 0 |
| SLVP | iShares MSCI Global Silver and Metals Miners ETF | 0.0% | 0.32 | 0 |
| SMIN | iShares MSCI India Small-Cap ETF | 0.0% | 0.34 | 0 |
| RING | iShares MSCI Global Gold Miners ETF | 0.0% | 0.36 | 0 |
| PFF | iShares Preferred and Income Securities ETF | 0.0% | 0.42 | 0 |
| PICK | iShares MSCI Global Metals & Mining Producers ETF | 0.0% | 0.47 | 0 |
| USRT | iShares Core U.S. REIT ETF | 0.0% | 0.54 | 0 |
| IYR | iShares U.S. Real Estate ETF | 0.0% | 0.54 | 0 |
Cost, returns and risk
| Expense ratio | 0.55% |
|---|---|
| Dividend yield | 0.24% |
| Total return, 1 year | 27.1% |
| Total return, 3 years cumulative | 67.0% |
| Total return, 5 years cumulative | 20.7% |
| Volatility, annualised | 17.0% |
| Worst fall, 3 years | -16.2% |
| Beta against SPY, 3 years of weekly returns | 0.64 |
| Weight in the ten largest positions | 42.6% |
| Largest single position | 5.6% |
Expense ratio, yield and assets are reference data; the weight in the ten largest positions and the largest single position are from the issuer file of 2026-10-27; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.52loosely linked | 123 |
| QQQ | 0.39barely linked | 130 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 19.5% |
| 2025 | 21.8% |
| 2024 | 1.6% |
| 2023 | 5.7% |
| 2022 | -19.7% |
One year
Where to go next
- CANC, Tema Oncology ETF
- FBT, First Trust NYSE Arca Biotechnology Index Fund
- FMED, Fidelity Disruptive Medicine ETF
- GNOM, Global X Genomics & Biotechnology ETF
- Run a portfolio x-ray to see what BMED carries once you look through it
- Compare BMED against any other ETF in the builder
Holdings from the most recent file iShares has published, dated 2026-10-27. Prices through 2026-10-28. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, iShares Health Innovation Active ETF (BMED), holdings from the issuer's file of 2026-10-27, https://tickerinside.com/etf/bmed/, CC BY 4.0
<a href="https://tickerinside.com/etf/bmed/">TickerInside</a> (https://tickerinside.com/etf/bmed/)